
Project details
Israeli medical equipment company seeks investment.
Project region | Israel |
---|---|
Industry | Healthcare |
Total value of the target | N/A |
Expected target net rate of return after deducting all taxes and fees | N/A |
Validity period of pending order | 365 |
CONTACT ADVISOR
Project highlights | Ophthalmology Department - FDA 505 (b)(2) |
---|---|
Project description |
The Israeli medical equipment company has a solution for outpatient ophthalmology departments, which can control the release of ophthalmic drugs over time, so as to solve the problem of inaccurate eye drop dispensing, enabling patients to 100% comply with the drug treatment plan. The device can be applied to the most prescribed glaucoma drugs. The product has completed a clinical study under the regulatory pathway procedure of FDA 505 (b) (2) as part of the application of new drugs. The goal of the company is to further develop the platform to treat other eye diseases. At present, the company seeks investment for its next step. |

We provide expert advisory and corporate services across Asia, guiding businesses through complex markets and regulations.
Have Any Questions?
Reach out to our local experts, we’ll respond within one business day.
Our Clients
Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.
See what our clients say about us